anti-cd20/19 car-t cell therapy in r/r b-cell malignancies
Published 2 years ago • 137 plays • Length 2:10Download video MP4
Download video MP3
Similar videos
-
1:33
cd20-targeted car t-cell therapy for patients with indolent b-cell nhl
-
2:42
dual-targeted anti-cd19/anti-cd20 car t-cells in r/r mcl: insights from a phase i/ii trial
-
0:45
bispecific car t-cell therapy: combining anti-cd19 and cd22 car t-cells
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
1:21
anti-cd22 car t-cell therapy for all: trial update, utility for salvage and cd19 status
-
0:37
hot topics in car t-cell therapy for all
-
4:10
car t-cell therapy for all
-
0:48
asciminib for the treatment of cml
-
1:09
the evolution of car t-cell therapy
-
2:05
the cost-effectiveness of car t-cell therapy
-
3:12
safety & efficacy of lv20.19 car-t therapy in richter's transformation and r/r mcl
-
2:51
car t-cell therapy: crs and adverse effects
-
3:33
an overview of the car t-cell therapy story
-
1:58
car t-cell therapy and all: the current landscape
-
8:27
anti cd7 car t-cell therapy in t-all
-
1:39
the role of myeloid cells in car-t cell therapy
-
2:26
clinical data for cd19-directed car t-cell products in all
-
4:06
car t-cells in adult all
-
3:10
universal car-t therapy for t-all